[METABOLIC EFFECTS OF PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE IN THE HEALTHY MAN AND IN THE PATIENT WITH ISCHEMIC HEART DISEASE. I. CLINICAL AND EXPERIMENTAL PHARMACOLOGY OF FEDIPRA].
D001713:Biphenyl Compounds; D003324:Coronary Artery Disease; D003327:Coronary Disease; D017202:Myocardial Ischemia; D010600:Pharmacology; D011299:Prenylamine; D014116:Toxicology
D001713:Biphenyl Compounds; D011299:Prenylamine; C010574:biphenyl
CORONARY DISEASE; PHARMACOLOGY; PRENYLAMINE; TOXICOLOGIC REPORT
EFFETTI METABOLICI DELLA FENIL-PROPIL-DIFENIL-PROPIL-AMINA NELL'UOMO SANO E NEL MALATO DI CARDIOPATIA ISCHEMICA. I. FARMACOLOGIA SPERIMENTALE E CLINICA DEL FEDIPRA.